▶ 調査レポート

世界の医薬品ハイドロコロイド市場予測(~2028年):海藻ハイドロコロイド、アラビアガム、カラギーナン&寒天、キサンタンガム

• 英文タイトル:Global Pharmaceutical Hydrocolloids Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の医薬品ハイドロコロイド市場予測(~2028年):海藻ハイドロコロイド、アラビアガム、カラギーナン&寒天、キサンタンガム / Global Pharmaceutical Hydrocolloids Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 / GIR-22E2079資料のイメージです。• レポートコード:GIR-22E2079
• 出版社/出版日:GlobalInfoResearch / 2022年5月
• レポート形態:英文、PDF、98ページ
• 納品方法:Eメール(2~3営業日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
医薬品ハイドロコロイド市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の医薬品ハイドロコロイドの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

医薬品ハイドロコロイド市場は種類と用途によって区分されます。2017年~2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・海藻ハイドロコロイド、アラビアガム、カラギーナン&寒天、キサンタンガム

用途別セグメントは次のように区分されます。
・医薬品、医療、その他

世界の医薬品ハイドロコロイド市場の主要な市場プレーヤーは以下のとおりです。
・DuPont、Cargill、Ingredion、CP Kelco、Kerry Group、Royal DSM

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、医薬品ハイドロコロイド製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な医薬品ハイドロコロイドメーカーの企業概要、2019年~2022年までの医薬品ハイドロコロイドの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な医薬品ハイドロコロイドメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年~2028年までの地域別医薬品ハイドロコロイドの販売量、売上、成長性を示しています。
・第5、6章では、2017年~2028年までの医薬品ハイドロコロイドの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域での医薬品ハイドロコロイド市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および医薬品ハイドロコロイドの産業チェーンを掲載しています。
・第13、14、15章では、医薬品ハイドロコロイドの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):DuPont、Cargill、Ingredion、CP Kelco、Kerry Group、Royal DSM
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年:海藻ハイドロコロイド、アラビアガム、カラギーナン&寒天、キサンタンガム
・用途別分析2017年-2028年:医薬品、医療、その他
・医薬品ハイドロコロイドの北米市場規模2017年-2028年:アメリカ、カナダ、メキシコ
・医薬品ハイドロコロイドのヨーロッパ市場規模2017年-2028年:ドイツ、イギリス、フランス、ロシア、イタリア
・医薬品ハイドロコロイドのアジア市場規模2017年-2028年:中国、日本、韓国、インド、東南アジア、オーストラリア
・医薬品ハイドロコロイドの南米市場規模2017年-2028年:ブラジル、アルゼンチン
・医薬品ハイドロコロイドの中東・アフリカ市場規模2017年-2028年:サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Pharmaceutical Hydrocolloids market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pharmaceutical Hydrocolloids market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Pharmaceuticals accounting for % of the Pharmaceutical Hydrocolloids global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Seaweed Hydrocolloids segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Pharmaceutical Hydrocolloids include DuPont, Cargill, Ingredion, CP Kelco, and Kerry Group, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pharmaceutical Hydrocolloids market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Seaweed Hydrocolloids
Arabic Gum
Carrageenan and Agar
Xanthan Gum
Market segment by Application can be divided into
Pharmaceuticals
Healthcare
Others
The key market players for global Pharmaceutical Hydrocolloids market are listed below:
DuPont
Cargill
Ingredion
CP Kelco
Kerry Group
Royal DSM
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharmaceutical Hydrocolloids product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pharmaceutical Hydrocolloids, with price, sales, revenue and global market share of Pharmaceutical Hydrocolloids from 2019 to 2022.
Chapter 3, the Pharmaceutical Hydrocolloids competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Hydrocolloids breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Pharmaceutical Hydrocolloids market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical Hydrocolloids.
Chapter 13, 14, and 15, to describe Pharmaceutical Hydrocolloids sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Pharmaceutical Hydrocolloids Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pharmaceutical Hydrocolloids Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Seaweed Hydrocolloids
1.2.3 Arabic Gum
1.2.4 Carrageenan and Agar
1.2.5 Xanthan Gum
1.3 Market Analysis by Application
1.3.1 Overview: Global Pharmaceutical Hydrocolloids Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pharmaceuticals
1.3.3 Healthcare
1.3.4 Others
1.4 Global Pharmaceutical Hydrocolloids Market Size & Forecast
1.4.1 Global Pharmaceutical Hydrocolloids Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Pharmaceutical Hydrocolloids Sales in Volume (2017-2028)
1.4.3 Global Pharmaceutical Hydrocolloids Price (2017-2028)
1.5 Global Pharmaceutical Hydrocolloids Production Capacity Analysis
1.5.1 Global Pharmaceutical Hydrocolloids Total Production Capacity (2017-2028)
1.5.2 Global Pharmaceutical Hydrocolloids Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pharmaceutical Hydrocolloids Market Drivers
1.6.2 Pharmaceutical Hydrocolloids Market Restraints
1.6.3 Pharmaceutical Hydrocolloids Trends Analysis
2 Manufacturers Profiles
2.1 DuPont
2.1.1 DuPont Details
2.1.2 DuPont Major Business
2.1.3 DuPont Pharmaceutical Hydrocolloids Product and Services
2.1.4 DuPont Pharmaceutical Hydrocolloids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Cargill
2.2.1 Cargill Details
2.2.2 Cargill Major Business
2.2.3 Cargill Pharmaceutical Hydrocolloids Product and Services
2.2.4 Cargill Pharmaceutical Hydrocolloids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Ingredion
2.3.1 Ingredion Details
2.3.2 Ingredion Major Business
2.3.3 Ingredion Pharmaceutical Hydrocolloids Product and Services
2.3.4 Ingredion Pharmaceutical Hydrocolloids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 CP Kelco
2.4.1 CP Kelco Details
2.4.2 CP Kelco Major Business
2.4.3 CP Kelco Pharmaceutical Hydrocolloids Product and Services
2.4.4 CP Kelco Pharmaceutical Hydrocolloids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Kerry Group
2.5.1 Kerry Group Details
2.5.2 Kerry Group Major Business
2.5.3 Kerry Group Pharmaceutical Hydrocolloids Product and Services
2.5.4 Kerry Group Pharmaceutical Hydrocolloids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Royal DSM
2.6.1 Royal DSM Details
2.6.2 Royal DSM Major Business
2.6.3 Royal DSM Pharmaceutical Hydrocolloids Product and Services
2.6.4 Royal DSM Pharmaceutical Hydrocolloids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Pharmaceutical Hydrocolloids Breakdown Data by Manufacturer
3.1 Global Pharmaceutical Hydrocolloids Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Pharmaceutical Hydrocolloids Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Pharmaceutical Hydrocolloids
3.4 Market Concentration Rate
3.4.1 Top 3 Pharmaceutical Hydrocolloids Manufacturer Market Share in 2021
3.4.2 Top 6 Pharmaceutical Hydrocolloids Manufacturer Market Share in 2021
3.5 Global Pharmaceutical Hydrocolloids Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Pharmaceutical Hydrocolloids Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pharmaceutical Hydrocolloids Market Size by Region
4.1.1 Global Pharmaceutical Hydrocolloids Sales in Volume by Region (2017-2028)
4.1.2 Global Pharmaceutical Hydrocolloids Revenue by Region (2017-2028)
4.2 North America Pharmaceutical Hydrocolloids Revenue (2017-2028)
4.3 Europe Pharmaceutical Hydrocolloids Revenue (2017-2028)
4.4 Asia-Pacific Pharmaceutical Hydrocolloids Revenue (2017-2028)
4.5 South America Pharmaceutical Hydrocolloids Revenue (2017-2028)
4.6 Middle East and Africa Pharmaceutical Hydrocolloids Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Pharmaceutical Hydrocolloids Sales in Volume by Type (2017-2028)
5.2 Global Pharmaceutical Hydrocolloids Revenue by Type (2017-2028)
5.3 Global Pharmaceutical Hydrocolloids Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Pharmaceutical Hydrocolloids Sales in Volume by Application (2017-2028)
6.2 Global Pharmaceutical Hydrocolloids Revenue by Application (2017-2028)
6.3 Global Pharmaceutical Hydrocolloids Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Pharmaceutical Hydrocolloids Sales by Type (2017-2028)
7.2 North America Pharmaceutical Hydrocolloids Sales by Application (2017-2028)
7.3 North America Pharmaceutical Hydrocolloids Market Size by Country
7.3.1 North America Pharmaceutical Hydrocolloids Sales in Volume by Country (2017-2028)
7.3.2 North America Pharmaceutical Hydrocolloids Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Pharmaceutical Hydrocolloids Sales by Type (2017-2028)
8.2 Europe Pharmaceutical Hydrocolloids Sales by Application (2017-2028)
8.3 Europe Pharmaceutical Hydrocolloids Market Size by Country
8.3.1 Europe Pharmaceutical Hydrocolloids Sales in Volume by Country (2017-2028)
8.3.2 Europe Pharmaceutical Hydrocolloids Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Pharmaceutical Hydrocolloids Sales by Type (2017-2028)
9.2 Asia-Pacific Pharmaceutical Hydrocolloids Sales by Application (2017-2028)
9.3 Asia-Pacific Pharmaceutical Hydrocolloids Market Size by Region
9.3.1 Asia-Pacific Pharmaceutical Hydrocolloids Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Pharmaceutical Hydrocolloids Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Pharmaceutical Hydrocolloids Sales by Type (2017-2028)
10.2 South America Pharmaceutical Hydrocolloids Sales by Application (2017-2028)
10.3 South America Pharmaceutical Hydrocolloids Market Size by Country
10.3.1 South America Pharmaceutical Hydrocolloids Sales in Volume by Country (2017-2028)
10.3.2 South America Pharmaceutical Hydrocolloids Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pharmaceutical Hydrocolloids Sales by Type (2017-2028)
11.2 Middle East & Africa Pharmaceutical Hydrocolloids Sales by Application (2017-2028)
11.3 Middle East & Africa Pharmaceutical Hydrocolloids Market Size by Country
11.3.1 Middle East & Africa Pharmaceutical Hydrocolloids Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Pharmaceutical Hydrocolloids Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Pharmaceutical Hydrocolloids and Key Manufacturers
12.2 Manufacturing Costs Percentage of Pharmaceutical Hydrocolloids
12.3 Pharmaceutical Hydrocolloids Production Process
12.4 Pharmaceutical Hydrocolloids Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Pharmaceutical Hydrocolloids Typical Distributors
13.3 Pharmaceutical Hydrocolloids Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer